031/21/2025 – iQure secures formal approval from the Human Research Ethics Committee (HREC) in Australia for the iQ-007 Phase 1 study.
Excellent news, proud to be first to introduce iQ-007 unique and broadly applicable glutamate uptake enhancer to clinical development. Thanks to all involved, including Jagiellonian University and our investors, for superb support!